Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial
2026 · European Heart Journal · 0 citations
https://doi.org/10.1093/eurheartj/ehag073
LMU Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
1
Citations
1
h-index
0
i10-index
Klaus G Parhofer is an academic researcher from LMU Klinikum. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Coagulation, Bradykinin, Polyphosphates, and Angioedema & Lipid metabolism and disorders. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat